Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Amlodipine as add-on to Olmesartan in Hypertension [Phase 3]
Phase 3 trial evaluating amlodipine as an add-on to olmesartan for essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: The Confirmatory Olmesartan Plaque Regression Study [Phase 4]
Phase 4 trial update for olmesartan examining plaque regression in carotid atherosclerosis; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Olmesartan as an add-on to Amlodipine in Hypertension [Phase 3]
A Phase 3 clinical trial evaluating olmesartan added to amlodipine for essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Study of CS-3150 in Patients With Essential Hypertension [Phase 3]
Phase 3 clinical trial update for CS-3150 in patients with essential hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension [Phase 3]
Phase 3 clinical trial update evaluating olmesartan alone or with hydrochlorothiazide in adults with essential hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension [NA]
Completed series of N-of-1 crossover trials evaluating antihypertensive therapy in adolescents with essential hypertension; results posted i…
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Essential Hypertension [Phase 2]
Phase 2 clinical trial update for essential hypertension completed.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment [Phase 4]
Phase 4 trial update evaluating the prognostic value of circadian patterns in ambulatory blood pressure for risk assessment in hypertension …
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: The Effects of Renal Denervation on Insulin Sensitivity [NA]
A clinical trial assessing the effects of renal denervation on insulin sensitivity in participants with treatment-resistant essential hypert…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Use of Metabolomics to Differentiate the Antihypertensive Effect of Acupuncture From Sham Acupuncture in Hypertensives [NA]
A completed clinical trial used metabolomics to differentiate the antihypertensive effects of acupuncture from sham acupuncture in people wi…
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant Hypertension [NA]
A first-in-human study is evaluating a novel catheter device for treatment-resistant hypertension.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Loaded Breathing Training in Essential Hypertension [NA]
Clinical trial of loaded breathing training for essential hypertension was terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension [Phase 2]
Phase 2 study evaluating the 24-hour antihypertensive efficacy of Fimasartan in adults with mild-to-moderate essential hypertension. The stu…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Uric Acid in Essential Hypertension in Children [Phase 2]
Phase 2 trial update on uric acid in essential hypertension in children; study status completed.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R [Phase 4]
Phase 4 clinical trial comparing azilsartan to telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension [Phase 4]
Phase 4 clinical trial update comparing two fixed-dose regimens in essential hypertension: S-amlodipine with chlorthalidone versus S-amlodip…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Fimasartan Achieving SBP Target (FAST) Study [Phase 4]
A Phase 4 trial (FAST) of fimasartan completed, reporting achievement of systolic blood pressure target in patients with essential hypertens…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects [Phase 4]
A Phase 4 clinical trial has completed evaluating the antiplatelet effects of a standardized tomato extract in adults with essential hyperte…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension [Phase 3]
This report covers the completion of a Phase III long-term study of TAK-536TCH in participants with essential hypertension. Results have bee…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Helius in Hypertension-I: The UK Hypertension Registry
Helius in Hypertension-I: The UK Hypertension Registry trial has completed and posted results in 2017, sponsored by Proteus Digital Health.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension [Phase 2]
Phase 2 study comparing the combination of nifedipine GITS and candesartan against monotherapy in essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Study of Efficacy and Safety of CVAA489 in Hypertensive Patients [Phase 4]
This update presents the results of a Phase 4 trial evaluating the efficacy and safety of CVAA489 in adults with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
Observational study to evaluate the safety of DILATREND SR Capsule in Korean patients with essential hypertension, chronic stable angina, an…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. [Phase 3]
Phase 3 trial comparing aliskiren 300 mg with irbesartan 300 mg and ramipril 10 mg in adults with essential hypertension, examining efficacy…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension [Phase 3]
A Phase 3 trial update reports long-term safety data for SPA100, a fixed-dose combination of aliskiren and amlodipine, in adults with essent…